PhuturdexDrug Pipeline Intelligence

Phuturdex › Diseases › Mediastinal neoplasm

Drugs in development · updated 30 October 2026

Mediastinal neoplasm: drugs in development

As of 30 October 2026 there are 3 active clinical trials (recruiting or ongoing, phases I–III) on 9 drugs for mediastinal neoplasm. 0 are experimental, that is not yet approved in the United States.

3Active trials
0Experimental drugs
0Experimental, in phase III

Summary updated every week · data as of 30 October 2026. In Phuturdex you get the full detail of every drug and an email when an alert is published on the ones you follow.

Sign in free →

Approved drugs in new trials

Approved by the US FDA for at least one indication, not necessarily this disease, and now in active trials on it.

DrugMost advanced phaseActive trialsReference trial
CarboplatinCarboplatine, ParaplatinII–III1NCT07463313
CisplatinCis Platinum, CisplatineII–III1NCT07463313
CyclophosphamideCyclophosphamid, CytoxanII–III1NCT07463313
DoxorubicinAdriamycin, DoxorubincinII–III1NCT07463313
Nab-paclitaxelAbraxane, Nab-placlitaxelII–III1NCT07463313
AtorvastatinLipitor, Atorvaliq®II1NCT07685938
Ethiodized OilLipiodolII1NCT05672108
LisinoprilQbrelis®, Zestril®II1NCT07685938
Mitomycin CMitomycin, JelmytoII1NCT05672108

Sorted by most advanced phase and number of active trials.

All 9 drugs, with the details

In Phuturdex every drug has all its trials, sponsors and countries, FDA and EMA approvals, orphan designations and safety alerts. Free until 31 March 2027.

Open in Phuturdex →

Broader categories

Source: Phuturdex analysis of ClinicalTrials.gov data (U.S. National Library of Medicine), updated 30 October 2026. Active trials = recruiting or ongoing, phases I–III, with at least one identified drug; phase and sites refer to the trials on this disease. Disease name: Wikidata; NLM MeSH term: D008479 “Mediastinal Neoplasms”.

ItalianoFrançaisDeutsch